Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Medpace Holdings, Inc. (MEDP : NSDQ)
 
 • Company Description   
Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio.

Number of Employees: 6,200

 
 • Price / Volume Information   
Yesterday's Closing Price: $669.20 Daily Weekly Monthly
20 Day Moving Average: 332,400 shares
Shares Outstanding: 27.91 (millions)
Market Capitalization: $18,678.57 (millions)
Beta: 1.18
52 Week High: $684.52
52 Week Low: $373.00
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 7.83% 8.97%
12 Week 15.72% 12.89%
Year To Date 19.15% 4.01%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
5375 MEDPACE WAY
-
CINCINNATI,OH 45227
USA		 ph: 513-579-9911
fax: 513-579-0444		 investor@medpace.com http://www.medpace.com
 
 • General Corporate Information   
Officers
August J. Troendle - Chief Executive Officer and Chairman of the Board
Kevin M. Brady - Chief Financial Officer
Brian T. Carley - Director
Robert O. Kraft - Director
Fred B. Davenport Jr. - Director

Peer Information
Medpace Holdings, Inc. (CHCR)
Medpace Holdings, Inc. (ESRX)
Medpace Holdings, Inc. (MYDP)
Medpace Holdings, Inc. (COR)
Medpace Holdings, Inc. (GBCS)
Medpace Holdings, Inc. (LAXAF)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 58506Q109
SIC: 8731
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 09/01/26
Next Expected EPS Date: 02/08/27
Share - Related Items
Shares Outstanding: 27.91
Most Recent Split Date: (:1)
Beta: 1.18
Market Capitalization: $18,678.57 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $4.64 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $17.61 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: 12.78% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 02/08/27  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 38.00
Trailing 12 Months: 37.10
PEG Ratio: 2.97
Price Ratios
Price/Book: 31.93
Price/Cash Flow: 39.33
Price / Sales: 6.58
EPS Growth
vs. Year Ago Period: 25.39%
vs. Previous Quarter: 13.88%
Sales Growth
vs. Year Ago Period: 8.50%
vs. Previous Quarter: 1.23%
ROE
09/30/26 - 99.76
06/30/26 - 110.15
03/31/26 - 120.89
ROA
09/30/26 - 24.47
06/30/26 - 24.84
03/31/26 - 24.79
Current Ratio
09/30/26 - 0.83
06/30/26 - 0.73
03/31/26 - 0.85
Quick Ratio
09/30/26 - -
06/30/26 - 0.73
03/31/26 - 0.85
Operating Margin
09/30/26 - 18.24
06/30/26 - 17.67
03/31/26 - 17.19
Net Margin
09/30/26 - 18.24
06/30/26 - 17.67
03/31/26 - 17.19
Pre-Tax Margin
09/30/26 - 22.09
06/30/26 - 21.53
03/31/26 - 21.35
Book Value
09/30/26 - 20.96
06/30/26 - 15.54
03/31/26 - 20.95
Inventory Turnover
09/30/26 - -
06/30/26 - -
03/31/26 - -
Debt-to-Equity
09/30/26 - -
06/30/26 - 0.00
03/31/26 - 0.00
Debt-to-Capital
09/30/26 - -
06/30/26 - 0.00
03/31/26 - 0.00
 

Powered by Zacks Investment Research ©